Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

被引:0
作者
Frangoul, Haydar [1 ]
Locatelli, Franco [2 ]
Corbacioglu, Selim [3 ]
De La Fuente, Josu [4 ]
Wall, Donna [5 ]
Cappellini, Maria Domenica [6 ]
de Montalembert, Mariane [7 ]
Kattamis, Antonis [8 ]
Lobitz, Stephan [9 ]
Rondelli, Damiano [10 ]
Sheth, Sujit [11 ]
Steinberg, Martin [12 ]
Walters, Mark [13 ]
Bobruff, Yael [14 ]
Simard, Chris [14 ]
Song, Yang [14 ]
Zhang, Lanju [14 ]
Sharma, Anjali [15 ]
Imren, Suzan [14 ]
Hobbs, Bill [14 ]
Grupp, Stephan A. [16 ]
机构
[1] Childrens Hosp TriStar Centennial, Nashville, TN USA
[2] Uni Rome, Rome, Italy
[3] Uni Regensburg, Regensburg, Germany
[4] Imperial Coll London, St Albans, England
[5] Hosp Sick Children, Toronto, ON, Canada
[6] Uni Milan, Milan, Italy
[7] Uni Paris, Paris, France
[8] Uni Athens, Athens, Greece
[9] Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany
[10] Uni Ill Chicago, Chicago, IL USA
[11] Weill Cornell Med, New York, NY USA
[12] BU Sch Med, Boston, MA USA
[13] UCSF Benioff Childrens Hosp, Oakland, CA USA
[14] Vertex Pharmaceut, Boston, MA USA
[15] CRISPR Therapeut, Cambridge, MA USA
[16] Uni Penn, Perelman Sch Med, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1
引用
收藏
页码:1 / 1
页数:1
相关论文
共 50 条
[21]   Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia [J].
de la Fuente, Josu ;
Locatelli, Franco ;
Lang, Peter ;
Meisel, Roland ;
Wall, Donna ;
Corbacioglu, Selim ;
Li, Amanda M. ;
Shah, Ami J. ;
Mapara, Markus Y. ;
Liem, Robert I. ;
Merkeley, Hayley Lynne ;
Kuo, Kevin H. M. ;
Rupprecht, Joachim ;
Kohli, Puja ;
Li, Nanxin ;
Rubin, Jaime ;
Zhang, Siyu ;
Liu, Tina ;
Hobbs, William ;
Frangoul, Haydar .
BLOOD, 2024, 144 :7454-7455
[22]   Evaluation of home desferal care in transfusion-dependent children with thalassemia and sickle cell disease [J].
Weissman, L ;
Treadwell, M ;
Vichinsky, E .
INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1997, 4 (01) :61-68
[23]   ECONOMIC EVALUATION OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) GENE-EDITED THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA [J].
Udeze, C. ;
Fang, H. ;
Ogunsile, F. J. ;
Mujumdar, U. ;
Nie, X. ;
Yang, H. ;
Jeyakumar, S. ;
Li, N. ;
Zhao, J. ;
Lopez, A. .
VALUE IN HEALTH, 2023, 26 (06) :S1-S1
[24]   MODEL-PROJECTED CLINICAL OUTCOMES OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN CANADA [J].
Udeze, C. ;
Gargano, M. ;
Kaindl, L. ;
Kane, S. ;
Zhou, A. ;
Jain, S. ;
Lopez, A. .
VALUE IN HEALTH, 2024, 27 (12) :S130-S130
[25]   BETIBEGLOGENE AUTOTEMCEL IN PEDIATRIC PTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA IN PHASE 3 TRIALS [J].
Lal, Ashutosh ;
Kwiatkowski, Janet ;
Thompson, Alexis ;
Thuret, Isabelle ;
Thrasher, Adrian ;
Kulozik, Andreas ;
Hongeng, Suradej ;
Yannaki, Evangelia ;
Sauer, Martin ;
Guo, Ruiting ;
Colvin, Richard ;
Locatelli, Franco ;
Walters, Mark .
PEDIATRIC BLOOD & CANCER, 2022, 69
[26]   Clinical Outcomes of Molecular Matching in Transfusion-Dependent Patients with Sickle Cell Disease (SCD) and Thalassemia [J].
de Macedo, Mayra Dorigan ;
dos Santos, Tamires Delfino ;
Perecin Menegati, Sheila Fatima ;
Pereira, Fabricio Biscaro ;
Gilli, Simone ;
Castilho, Lilian .
TRANSFUSION, 2017, 57 :137A-138A
[27]   Early safety and efficacy results with a single dose of autologous CRISPR-Cas9-modified CD34+hematopoietic stem and progenitor cells in transfusion-dependent β-thalassemia and sickle cell disease [J].
de la Fuente, Josu ;
Frangoul, Haydar ;
Bobruff, Yael ;
Cappellini, Maria Domenica ;
Corbacioglu, Selim ;
Fernandez, Christine Marie ;
Grupp, Stephan ;
Handgretinger, Rupert ;
Ho, Tony W. ;
Imren, Suzan ;
Kattamis, Antonis ;
Lekstrom-Himes, Julie ;
Locatelli, Franco ;
Lu, Yimeng ;
Mapara, Markus ;
Mulcahey, Sarah ;
de Montalembert, Mariane ;
Rondelli, Damiano ;
Shanbhag, Niraj ;
Sheth, Sujit ;
Soni, Sandeep ;
Steinberg, Martin H. ;
Weinstein, Michael ;
Wu, John ;
Wall, Donna .
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 :22-23
[28]   The effectiveness and value of betibeglogene autotemcel for the management of transfusion-dependent beta-thalassemia [J].
Lancaster, Victoria ;
Richardson, Marina ;
Beaudoin, Francesca L. ;
Synnott, Patricia G. ;
Rind, David M. ;
Herce-Hagiwara, Belen ;
Campbell, Jon ;
Pearson, Steven .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (11) :1316-1320
[29]   Elimination of vaso-occlusive crises after exagamglogene autotemcel in patients with severe Sickle Cell Disease [J].
Meisel, R. ;
Frangoul, H. ;
Locatelli, F. ;
Sharma, A. ;
Bhatia, M. ;
Molinari, L. ;
Wall, D. ;
Liem, R. ;
Telfer, P. ;
Shah, A. ;
Cavazzana, M. ;
Corbacioglu, S. ;
Rondelli, D. ;
Dedeken, L. ;
Lobitz, S. ;
de Montalembert, M. ;
Steinberg, M. ;
Walters, M. ;
Imren, S. ;
Shi, D. ;
Bower, L. ;
Simard, C. ;
Zhang, L. ;
Morrow, P. K. ;
Hobbs, B. ;
Grupp, S. .
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 :99-100
[30]   Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease [J].
Sharma, Akshay ;
Frangoul, Haydar ;
Mapara, Markus ;
Imren, Suzan ;
Li, Nanxin ;
Liu, Tina ;
Rubin, Jaime ;
Shi, Daoyuan ;
Hobbs, William ;
Grupp, Stephan .
BLOOD, 2023, 142